Clinical Trials Browser

Phase 2 × mCRC × trifluridine tipiracil drug combination × Clear all

NCT07116577 2025-08-11

Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC

Phase 2 Not yet recruiting

mCRC